ROCKET PHARMACEUTICALS, INC. (RCKT) › Total LiabilitiesROCKET PHARMACEUTICALS, INC. (RCKT) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2014: $10.28M2015: $4.51M2016: $56.48M2017: $4.63M2018: $57.28M2019: $64.82M2020: $87.31M2021: $42.30M2022: $62.12M2023: $73.77M2024: $64.47M2025: $53.23M$53.23M2014Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$53.23M-17.4%2024$64.47M-12.6%2023$73.77M+18.7%2022$62.12M+46.9%2021$42.30M-51.6%2020$87.31M+34.7%2019$64.82M+13.2%2018$57.28M+1137.6%2017$4.63M-91.8%2016$56.48M+1152.9%2015$4.51M-56.1%2014$10.28M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share